Equol

National Institute on AgingUS$2.8mNational Heart, Lung, and Blood InstituteUS$894kNational Institute of Arthritis and Musculoskeletal and Skin DiseasesUS$417.9k5 grants since 2022

• Equol Supplementation for Improving Vascular Function in Postmenopausal Women with CKD: Efficacy and Mechanistic Role of GPER

  National Heart, Lung, and Blood InstituteUniversity of Colorado, DenverUS$75.6k2025–2027

• Arterial Stiffness, Cognition, and Equol (ACE)

  National Institute on AgingUniversity of Pittsburgh at PittsburghUS$397.3k2022–2027

• Integrative Model of Metabolomics, Equol and Atherosclerotic cardiovascular disease (IMMEA)

  National Heart, Lung, and Blood InstituteUniversity of Pittsburgh at PittsburghUS$656.5k2024–2028

• Effects of Equol, the most bioactive soy isoflavone, on bone microarchitecture, density, strength and turnover

  National Institute of Arthritis and Musculoskeletal and Skin DiseasesUniversity of Pittsburgh at PittsburghUS$417.9k2026–2030

• 7T Vascular and Molecular Imaging of SVD: Sex, Equol, and Risk of Alzheimer’s Disease

  National Institute on AgingUniversity of Pittsburgh at PittsburghUS$726.3k2024–2029